Synthesis of Sensitive Oligodeoxynucleotides Containing Acylated Cytosine, Adenine, and Guanine Nucleobases
Komal Chillar,
No information about this author
Rohith Awasthy,
No information about this author
Marina Tanasova
No information about this author
et al.
DNA,
Journal Year:
2025,
Volume and Issue:
5(2), P. 25 - 25
Published: May 9, 2025
Background/Objective:
Oligodeoxynucleotides
(ODNs)
containing
base-labile
modifications
such
as
N4-acetyldeoxycytidine
(4acC),
N6-acetyladenosine
(6acA),
N2-acetylguanosine
(2acG),
and
N4-methyoxycarbonyldeoxycytidine
(4mcC)
are
highly
challenging
to
synthesize
because
standard
ODN
synthesis
methods
require
deprotection
cleavage
under
strongly
basic
nucleophilic
conditions,
there
is
a
lack
of
ideal
alternative
solve
the
problem.
The
objective
this
work
explore
capability
recently
developed
1,3-dithian-2-yl-methoxycarbonyl
(Dmoc)
method
for
incorporation
multiple
4acC
into
single
molecule
feasibility
using
6acA,
2acG
4mcC
ODNs.
Methods:
sensitive
ODNs
were
synthesized
on
an
automated
solid
phase
synthesizer
Dmoc
group
linker
methyl
(meDmoc)
protection
exo-amino
groups
nucleobases.
Deprotection
achieved
non-nucleophilic
weakly
conditions.
Results:
4acC,
2acG,
all
found
be
stable
mild
Up
four
able
incorporated
19-mer
molecule.
also
successfully
synthesized.
characterized
RP
HPLC,
capillary
electrophoresis,
gel
electrophoresis
MALDI
MS.
Conclusions:
Among
modified
nucleotides,
has
been
in
nature
proven
beneficial
DNA
duplex
stability.
A
expected
find
applications
biological
studies
involving
4acC.
Although
have
not
nature,
synthetic
route
them
facilitate
projects
aimed
at
studying
their
biophysical
properties
well
potential
antisense,
RNAi,
CRISPR,
mRNA
therapeutic
applications.
Language: Английский
Acetylcytidine modification of Amotl1 by N-acetyltransferase 10 contributes to cardiac fibrotic expansion in mice after myocardial infarction
Xiuxiu Wang,
No information about this author
Yiming Zhao,
No information about this author
Qian-yun Zhang
No information about this author
et al.
Acta Pharmacologica Sinica,
Journal Year:
2024,
Volume and Issue:
45(7), P. 1425 - 1437
Published: June 5, 2024
Language: Английский
RNA ac4C modification in cancer: Unraveling multifaceted roles and promising therapeutic horizons
Wenhao Ouyang,
No information about this author
Zhenjun Huang,
No information about this author
Keyu Wan
No information about this author
et al.
Cancer Letters,
Journal Year:
2024,
Volume and Issue:
601, P. 217159 - 217159
Published: Aug. 14, 2024
Language: Английский
A review of current developments in RNA modifications in lung cancer
Cancer Cell International,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Oct. 25, 2024
Lung
cancer
has
the
highest
incidence
and
mortality
rates
worldwide
is
primary
cause
of
cancer-related
death.
Despite
rapid
development
diagnostic
methods
targeted
drugs
in
recent
years,
many
lung
patients
do
not
benefit
from
effective
therapies.
The
emergence
drug
resistance
led
to
a
reduction
therapeutic
effectiveness
drugs,
highlighting
crucial
need
explore
novel
targets.
Many
studies
have
found
that
epigenetic
plays
an
important
role
occurrence
cancer.
This
review
describes
biological
function
RNA
modifications,
such
as
m6A,
m5C,
m7G,
m1A,
advancements
their
development,
progression,
prognosis
aims
provide
new
guidance
for
treatment
Language: Английский
The role and mechanism of NAT10‐mediated ac4C modification in tumor development and progression
Zhuoran Gu,
No information about this author
Libin Zou,
No information about this author
Xinjian Pan
No information about this author
et al.
MedComm,
Journal Year:
2024,
Volume and Issue:
5(12)
Published: Dec. 1, 2024
Abstract
RNA
modification
has
emerged
as
a
crucial
area
of
research
in
epigenetics,
significantly
influencing
tumor
biology
by
regulating
metabolism.
N‐acetyltransferase
10
(NAT10)‐mediated
N4‐acetylcytidine
(ac4C)
modification,
the
sole
known
acetylation
eukaryotic
RNA,
influences
cancer
pathogenesis
and
progression.
NAT10
is
only
writer
ac4C
catalyzes
acetyl
transfer
on
targeted
helps
to
improve
stability
translational
efficiency
ac4C‐modified
RNA.
highly
expressed
associated
with
poor
prognosis
pan‐cancers.
Based
its
molecular
mechanism
biological
functions,
central
factor
tumorigenesis,
progression,
drug
resistance,
immune
escape.
Despite
increasing
focus
ac4C,
specific
regulatory
mechanisms
remain
elusive.
The
present
review
thoroughly
analyzes
current
knowledge
NAT10‐mediated
cancer,
highlighting
broad
influence
gene
expression
biology.
This
also
summarizes
limitations
perspectives
identify
new
therapeutic
targets
advance
treatment
strategies.
Language: Английский